Watch a recording of a comprehensive webinar on the newly announced Health Canada XML Product Monograph (PM) July 18, 2025 deadline, a pivotal development for pharmaceutical companies operating in Canada. These deadlines represent a significant shift in regulatory requirements, and failing to comply could jeopardize market access and lead to potential financial and reputational risks. Understanding the intricacies of these changes is essential for ensuring compliance and maintaining a competitive edge. Watch now!

LexisNexis Reed Tech, with its proven track record of having successfully submitted over 50% of voluntary submissions, stands at the forefront of this regulatory transition. Our team of experts will provide an in-depth analysis of the new deadlines, highlighting the potential risks and implications for your organization. We will explore the critical steps involved in the preparation and submission process, offering practical guidance on how to navigate these changes effectively.

Participants will gain valuable insights into the regulatory landscape, including the specific requirements for XML PM submissions and the common pitfalls to avoid. Our experts will share strategies to streamline your submission processes, ensuring accuracy and efficiency while meeting Health Canada's stringent expectations. This webinar is an essential opportunity for regulatory professionals to enhance their understanding and readiness for the upcoming deadlines. Don't miss the chance to equip your organization with the knowledge and tools needed to succeed in this evolving regulatory environment!

Key Takeaways

• Understanding Health Canada's XML PM requirements to maintain market access and avoid risks
• Overview of key deadlines in the newly announced timeline, including what’s required by July 18, 2025
• Requirements for preparation and submission of XML PMs
• Common pitfalls identified by experienced LexisNexis Reed Tech experts

This session is crucial for regulatory professionals to stay compliant and competitive!